Targeting long non-coding RNA to therapeutically upregulate gene expression (original) (raw)

• Byrne, B. J., Falk, D. J., Clement, N. & Mah, C. S. Gene therapy approaches for lysosomal storage disease: next-generation treatment. Hum. Gene Ther. 23, 808–815 (2012).
  CAS PubMed PubMed Central Google Scholar
• Sheridan, C. Gene therapy finds its niche. Nature Biotech. 29, 121–128 (2011).
  CAS Google Scholar
• Ciesielska, A. et al. Cerebral infusion of AAV9 vector-encoding non-self proteins can elicit cell-mediated immune responses. Mol. Ther. 21, 158–166 (2013).
  CAS PubMed Google Scholar
• Unzu, C. et al. Transient and intensive pharmacological immunosuppression fails to improve AAV-based liver gene transfer in non-human primates. J. Transl. Med. 10, 122 (2012).
  CAS PubMed PubMed Central Google Scholar
• Waehler, R., Russell, S. J. & Curiel, D. T. Engineering targeted viral vectors for gene therapy. Nature Rev. Genet. 8, 573–587 (2007).
  CAS PubMed Google Scholar
• Mingozzi, F. & High, K. A. Therapeutic in vivo gene transfer for genetic disease using AAV: progress and challenges. Nature Rev. Genet. 12, 341–355 (2011).
  CAS PubMed Google Scholar
• Thrasher, A. J. et al. Gene therapy: X-SCID transgene leukaemogenicity. Nature 443, e5–e6 (2006).
  CAS PubMed Google Scholar
• Gaspar, H. B. et al. Long-term persistence of a polyclonal T cell repertoire after gene therapy for X-linked severe combined immunodeficiency. Sci. Transl. Med. 3, 97ra79 (2011).
  PubMed Google Scholar
• Woods, N. B., Bottero, V., Schmidt, M., von Kalle, C. & Verma, I. M. Gene therapy: therapeutic gene causing lymphoma. Nature 440, 1123 (2006).
  CAS PubMed Google Scholar
• Yla-Herttuala, S. Endgame: glybera finally recommended for approval as the first gene therapy drug in the European union. Mol. Ther. 20, 1831–1832 (2012).
  PubMed PubMed Central Google Scholar
• Overington, J. P., Al-Lazikani, B. & Hopkins, A. L. How many drug targets are there? Nature Rev. Drug Discov. 5, 993–996 (2006).
  CAS Google Scholar
• Karamouzis, M. V. & Papavassiliou, A. G. Transcription factor networks as targets for therapeutic intervention of cancer: the breast cancer paradigm. Mol. Med. 17, 1133–1136 (2011).
  CAS PubMed PubMed Central Google Scholar
• Libermann, T. A. & Zerbini, L. F. Targeting transcription factors for cancer gene therapy. Curr. Gene Ther. 6, 17–33 (2006).
  CAS PubMed Google Scholar
• Arrowsmith, C. H., Bountra, C., Fish, P. V., Lee, K. & Schapira, M. Epigenetic protein families: a new frontier for drug discovery. Nature Rev. Drug Discov. 11, 384–400 (2012).
  CAS Google Scholar
• Dawson, M. A. & Kouzarides, T. Cancer epigenetics: from mechanism to therapy. Cell 150, 12–27 (2012).
  CAS PubMed Google Scholar
• Lindow, M. & Kauppinen, S. Discovering the first microRNA-targeted drug. J. Cell Biol. 199, 407–412 (2012).
  CAS PubMed PubMed Central Google Scholar
• Thum, T. MicroRNA therapeutics in cardiovascular medicine. EMBO Mol. Med. 4, 3–14 (2012).
  CAS PubMed PubMed Central Google Scholar
• Broderick, J. A. & Zamore, P. D. MicroRNA therapeutics. Gene Ther. 18, 1104–1110 (2011).
  CAS PubMed PubMed Central Google Scholar
• Wang, V. & Wu, W. MicroRNA-based therapeutics for cancer. BioDrugs 23, 15–23 (2009).
  PubMed Google Scholar
• Sun, W., Julie Li, Y. S., Huang, H. D., Shyy, J. Y. & Chien, S. microRNA: a master regulator of cellular processes for bioengineering systems. Annu. Rev. Biomed. Eng. 12, 1–27 (2010).
  CAS PubMed Google Scholar
• Wahlestedt, C. Natural antisense and noncoding RNA transcripts as potential drug targets. Drug Discov. Today 11, 503–508 (2006). This is the first non-patent publication to describe the antagoNAT strategy.
  CAS PubMed Google Scholar
• Schwartz, J. C. et al. Antisense transcripts are targets for activating small RNAs. Nature Struct. Mol. Biol. 15, 842–848 (2008).
  CAS Google Scholar
• Morris, K. V. Long antisense non-coding RNAs function to direct epigenetic complexes that regulate transcription in human cells. Epigenetics 4, 296–301 (2009).
  CAS PubMed Google Scholar
• Carninci, P. et al. The transcriptional landscape of the mammalian genome. Science 309, 1559–1563 (2005). This study describes the large-scale effort required to produce data showing that the mammalian genome is pervasively transcribed.
  CAS PubMed Google Scholar
• Cheng, J. et al. Transcriptional maps of 10 human chromosomes at 5-nucleotide resolution. Science 308, 1149–1154 (2005).
  CAS PubMed Google Scholar
• Dunham, I. et al. An integrated encyclopedia of DNA elements in the human genome. Nature 489, 57–74 (2012).
  CAS Google Scholar
• Djebali, S. et al. Landscape of transcription in human cells. Nature 489, 101–108 (2012). This study also describes the large-scale effort required to produce data showing that the mammalian genome is pervasively transcribed.
  CAS PubMed PubMed Central Google Scholar
• Derrien, T. et al. The GENCODE v7 catalog of human long noncoding RNAs: analysis of their gene structure, evolution, and expression. Genome Res. 22, 1775–1789 (2012).
  CAS PubMed PubMed Central Google Scholar
• Mattick, J. S. The functional genomics of noncoding RNA. Science 309, 1527–1528 (2005).
  CAS PubMed Google Scholar
• Graifer, D. & Karpova, G. Structural and functional topography of the human ribosome. Acta Biochim. Biophys. Sin. 44, 281–299 (2012).
  CAS PubMed Google Scholar
• St Laurent, G. et al. Intronic RNAs constitute the major fraction of the non-coding RNA in mammalian cells. BMC Genomics 13, 504 (2012).
  CAS PubMed PubMed Central Google Scholar
• Brown, C. J. et al. A gene from the region of the human X inactivation centre is expressed exclusively from the inactive X chromosome. Nature 349, 38–44 (1991).
  CAS PubMed Google Scholar
• Lee, J. T. Epigenetic regulation by long noncoding RNAs. Science 338, 1435–1439 (2012).
  CAS PubMed Google Scholar
• Taft, R. J., Pheasant, M. & Mattick, J. S. The relationship between non-protein-coding DNA and eukaryotic complexity. Bioessays 29, 288–299 (2007).
  CAS PubMed Google Scholar
• Mathews, D. H., Moss, W. N. & Turner, D. H. Folding and finding RNA secondary structure. Cold Spring Harb. Perspect. Biol. 2, a003665 (2010).
  CAS PubMed PubMed Central Google Scholar
• Wahlestedt, C. et al. Potent and nontoxic antisense oligonucleotides containing locked nucleic acids. Proc. Natl Acad. Sci. USA 97, 5633–5638 (2000).
  CAS PubMed PubMed Central Google Scholar
• Khalil, A. M., Faghihi, M. A., Modarresi, F., Brothers, S. P. & Wahlestedt, C. A novel RNA transcript with antiapoptotic function is silenced in fragile X syndrome. PLoS ONE 3, e1486 (2008).
  PubMed PubMed Central Google Scholar
• Katayama, S. et al. Antisense transcription in the mammalian transcriptome. Science 309, 1564–1566 (2005). This paper describes a large-scale effort to show that extensive and functionally relevant antisense transcription occurs in the mammalian genome.
  PubMed Google Scholar
• Engstrom, P. G. et al. Complex loci in human and mouse genomes. PLoS Genet. 2, e47 (2006).
  PubMed PubMed Central Google Scholar
• Khalil, A. M. et al. Many human large intergenic noncoding RNAs associate with chromatin-modifying complexes and affect gene expression. Proc. Natl Acad. Sci. USA 106, 11667–11672 (2009). This paper demonstrates that many lncRNAs are not associated with protein-coding loci.
  CAS PubMed PubMed Central Google Scholar
• Guttman, M. et al. Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals. Nature 458, 223–227 (2009).
  CAS PubMed PubMed Central Google Scholar
• Guttman, M. et al. lincRNAs act in the circuitry controlling pluripotency and differentiation. Nature 477, 295–300 (2011). This is a large-scale demonstration showing that the function of many lncRNAs is not associated with protein-coding loci.
  CAS PubMed PubMed Central Google Scholar
• Kretz, M. et al. Control of somatic tissue differentiation by the long non-coding RNA TINCR. Nature 493, 231–235 (2013).
  CAS PubMed Google Scholar
• Nakaya, H. I. et al. Genome mapping and expression analyses of human intronic noncoding RNAs reveal tissue-specific patterns and enrichment in genes related to regulation of transcription. Genome Biol. 8, R43 (2007).
  PubMed PubMed Central Google Scholar
• Faghihi, M. A. et al. RNAi screen indicates widespread biological function for human natural antisense transcripts. PLoS ONE 5, e13177 (2010). This is a large-scale demonstration of the function of many long non-coding NATs.
  PubMed PubMed Central Google Scholar
• Faghihi, M. A. & Wahlestedt, C. Regulatory roles of natural antisense transcripts. Nature Rev. Mol. Cell Biol. 10, 637–643 (2009).
  CAS Google Scholar
• Magistri, M., Faghihi, M. A., St Laurent, G. & Wahlestedt, C. Regulation of chromatin structure by long noncoding RNAs: focus on natural antisense transcripts. Trends Genet. 28, 389–396 (2012).
  CAS PubMed PubMed Central Google Scholar
• Faghihi, M. A. & Wahlestedt, C. RNA interference is not involved in natural antisense mediated regulation of gene expression in mammals. Genome Biol. 7, R38 (2006).
  PubMed PubMed Central Google Scholar
• Carrieri, C. et al. Long non-coding antisense RNA controls Uchl1 translation through an embedded SINEB2 repeat. Nature 491, 454–457 (2012).
  CAS PubMed Google Scholar
• Mohammad, F., Mondal, T. & Kanduri, C. Epigenetics of imprinted long noncoding RNAs. Epigenetics 4, 277–286 (2009).
  CAS PubMed Google Scholar
• Yang, L. et al. ncRNA- and Pc2 methylation-dependent gene relocation between nuclear structures mediates gene activation programs. Cell 147, 773–788 (2011).
  CAS PubMed PubMed Central Google Scholar
• Rinn, J. L. et al. Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs. Cell 129, 1311–1323 (2007).
  CAS PubMed PubMed Central Google Scholar
• Tsai, M. C. et al. Long noncoding RNA as modular scaffold of histone modification complexes. Science 329, 689–693 (2010).
  CAS PubMed PubMed Central Google Scholar
• Hung, T. et al. Extensive and coordinated transcription of noncoding RNAs within cell-cycle promoters. Nature Genet. 43, 621–629 (2011).
  CAS PubMed Google Scholar
• Huarte, M. et al. A large intergenic noncoding RNA induced by p53 mediates global gene repression in the p53 response. Cell 142, 409–419 (2010).
  CAS PubMed PubMed Central Google Scholar
• Feng, J. et al. The Evf-2 noncoding RNA is transcribed from the Dlx-5/6 ultraconserved region and functions as a Dlx-2 transcriptional coactivator. Genes Dev. 20, 1470–1484 (2006).
  CAS PubMed PubMed Central Google Scholar
• Wang, X. et al. Induced ncRNAs allosterically modify RNA-binding proteins in cis to inhibit transcription. Nature 454, 126–130 (2008).
  CAS PubMed PubMed Central Google Scholar
• Tripathi, V. et al. The nuclear-retained noncoding RNA MALAT1 regulates alternative splicing by modulating SR splicing factor phosphorylation. Mol. Cell 39, 925–938 (2010).
  CAS PubMed PubMed Central Google Scholar
• Eissmann, M. et al. Loss of the abundant nuclear non-coding RNA MALAT1 is compatible with life and development. RNA Biol. 9, 1076–1087 (2012).
  CAS PubMed PubMed Central Google Scholar
• Kino, T., Hurt, D. E., Ichijo, T., Nader, N. & Chrousos, G. P. Noncoding RNA Gas5 is a growth arrest- and starvation-associated repressor of the glucocorticoid receptor. Sci. Signal. 3, ra8 (2010).
  PubMed PubMed Central Google Scholar
• Bond, C. S. & Fox, A. H. Paraspeckles: nuclear bodies built on long noncoding RNA. J. Cell Biol. 186, 637–644 (2009).
  CAS PubMed PubMed Central Google Scholar
• Clemson, C. M. et al. An architectural role for a nuclear noncoding RNA: NEAT1 RNA is essential for the structure of paraspeckles. Mol. Cell 33, 717–726 (2009).
  CAS PubMed PubMed Central Google Scholar
• Salmena, L., Poliseno, L., Tay, Y., Kats, L. & Pandolfi, P. P. A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language? Cell 146, 353–358 (2011).
  CAS PubMed PubMed Central Google Scholar
• Cesana, M. et al. A long noncoding RNA controls muscle differentiation by functioning as a competing endogenous RNA. Cell 147, 358–369 (2011).
  CAS PubMed PubMed Central Google Scholar
• Kim, T. K. et al. Widespread transcription at neuronal activity-regulated enhancers. Nature 465, 182–187 (2010).
  CAS PubMed PubMed Central Google Scholar
• Sahu, B. et al. Dual role of FoxA1 in androgen receptor binding to chromatin, androgen signalling and prostate cancer. EMBO J. 30, 3962–3976 (2011).
  CAS PubMed PubMed Central Google Scholar
• Wang, D. et al. Reprogramming transcription by distinct classes of enhancers functionally defined by eRNA. Nature 474, 390–394 (2011).
  CAS PubMed PubMed Central Google Scholar
• Yap, K. L. et al. Molecular interplay of the noncoding RNA ANRIL and methylated histone H3 lysine 27 by polycomb CBX7 in transcriptional silencing of INK4a. Mol. Cell 38, 662–674 (2010).
  CAS PubMed PubMed Central Google Scholar
• Gupta, R. A. et al. Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature 464, 1071–1076 (2010).
  CAS PubMed PubMed Central Google Scholar
• Yang, Z. et al. Overexpression of long non-coding RNA HOTAIR predicts tumor recurrence in hepatocellular carcinoma patients following liver transplantation. Ann. Surg. Oncol. 18, 1243–1250 (2011).
  PubMed Google Scholar
• Kogo, R. et al. Long noncoding RNA HOTAIR regulates polycomb-dependent chromatin modification and is associated with poor prognosis in colorectal cancers. Cancer Res. 71, 6320–6326 (2011).
  CAS PubMed Google Scholar
• Niinuma, T. et al. Upregulation of miR-196a and HOTAIR drive malignant character in gastrointestinal stromal tumors. Cancer Res. 72, 1126–1136 (2012).
  CAS PubMed Google Scholar
• Gutschner, T. & Diederichs, S. The hallmarks of cancer: a long non-coding RNA point of view. RNA Biol. 9, 703–719 (2012).
  CAS PubMed PubMed Central Google Scholar
• Luo, J. H. et al. Transcriptomic and genomic analysis of human hepatocellular carcinomas and hepatoblastomas. Hepatology 44, 1012–1024 (2006).
  CAS PubMed Google Scholar
• Schmidt, L. H. et al. The long noncoding MALAT-1 RNA indicates a poor prognosis in non-small cell lung cancer and induces migration and tumor growth. J. Thorac. Oncol. 6, 1984–1992 (2011).
  PubMed Google Scholar
• Geng, Y. J., Xie, S. L., Li, Q., Ma, J. & Wang, G. Y. Large intervening non-coding RNA HOTAIR is associated with hepatocellular carcinoma progression. J. Int. Med. Res. 39, 2119–2128 (2011).
  CAS PubMed Google Scholar
• Kim, K. et al. HOTAIR is a negative prognostic factor and exhibits pro-oncogenic activity in pancreatic cancer. Oncogene 32, 1616–1625 (2012).
  PubMed PubMed Central Google Scholar
• Silva, J. M., Boczek, N. J., Berres, M. W., Ma, X. & Smith, D. I. LSINCT5 is over expressed in breast and ovarian cancer and affects cellular proliferation. RNA Biol. 8, 496–505 (2011).
  CAS PubMed Google Scholar
• Jendrzejewski, J. et al. The polymorphism rs944289 predisposes to papillary thyroid carcinoma through a large intergenic noncoding RNA gene of tumor suppressor type. Proc. Natl Acad. Sci. USA 109, 8646–8651 (2012).
  CAS PubMed PubMed Central Google Scholar
• Han, Y., Liu, Y., Gui, Y. & Cai, Z. Long intergenic non-coding RNA TUG1 is overexpressed in urothelial carcinoma of the bladder. J. Surg. Oncol. 107, 555–559 (2012).
  PubMed Google Scholar
• Tsang, W. P., Wong, T. W., Cheung, A. H., Co, C. N. & Kwok, T. T. Induction of drug resistance and transformation in human cancer cells by the noncoding RNA CUDR. RNA 13, 890–898 (2007).
  CAS PubMed PubMed Central Google Scholar
• Qureshi, I. A., Mattick, J. S. & Mehler, M. F. Long non-coding RNAs in nervous system function and disease. Brain Res. 1338, 20–35 (2010).
  CAS PubMed Google Scholar
• Pastori, C. & Wahlestedt, C. Involvement of long noncoding RNAs in diseases affecting the central nervous system. RNA Biol. 9, 860–870 (2012).
  CAS PubMed PubMed Central Google Scholar
• St Laurent, G. & Wahlestedt, C. Noncoding RNAs: couplers of analog and digital information in nervous system function? Trends Neurosci. 30, 612–621 (2007).
  CAS PubMed Google Scholar
• Mirkin, S. M. Expandable DNA repeats and human disease. Nature 447, 932–940 (2007).
  CAS PubMed Google Scholar
• Moseley, M. L. et al. Bidirectional expression of CUG and CAG expansion transcripts and intranuclear polyglutamine inclusions in spinocerebellar ataxia type 8. Nature Genet. 38, 758–769 (2006).
  CAS PubMed Google Scholar
• Cho, D. H. et al. Antisense transcription and heterochromatin at the DM1 CTG repeats are constrained by CTCF. Mol. Cell 20, 483–489 (2005).
  CAS PubMed Google Scholar
• Faghihi, M. A. et al. Expression of a noncoding RNA is elevated in Alzheimer's disease and drives rapid feed-forward regulation of β-secretase. Nature Med. 14, 723–730 (2008).
  CAS PubMed Google Scholar
• Mus, E., Hof, P. R. & Tiedge, H. Dendritic BC200 RNA in aging and in Alzheimer's disease. Proc. Natl Acad. Sci. USA 104, 10679–10684 (2007).
  CAS PubMed PubMed Central Google Scholar
• Johnson, R. et al. The human accelerated region 1 noncoding RNA is repressed by REST in Huntington's disease. Physiol. Genomics 41, 269–274 (2010).
  CAS PubMed Google Scholar
• Troy, A. & Sharpless, N. E. Genetic “lnc”-age of noncoding RNAs to human disease. J. Clin. Invest. 122, 3837–3840 (2012).
  CAS PubMed PubMed Central Google Scholar
• van Dijk, M. et al. HELLP babies link a novel lincRNA to the trophoblast cell cycle. J. Clin. Invest. 122, 4003–4011 (2012).
  CAS PubMed PubMed Central Google Scholar
• Maass, P. G. et al. A misplaced lncRNA causes brachydactyly in humans. J. Clin. Invest. 122, 3990–4002 (2012).
  CAS PubMed PubMed Central Google Scholar
• Millar, J. K. et al. Disruption of two novel genes by a translocation co-segregating with schizophrenia. Hum. Mol. Genet. 9, 1415–1423 (2000).
  CAS PubMed Google Scholar
• Ladd, P. D. et al. An antisense transcript spanning the CGG repeat region of FMR1 is upregulated in premutation carriers but silenced in full mutation individuals. Hum. Mol. Genet. 16, 3174–3187 (2007).
  CAS PubMed Google Scholar
• Cabianca, D. S. et al. A long ncRNA links copy number variation to a polycomb/trithorax epigenetic switch in FSHD muscular dystrophy. Cell 149, 819–831 (2012).
  CAS PubMed PubMed Central Google Scholar
• Wapinski, O. & Chang, H. Y. Long noncoding RNAs and human disease. Trends Cell Biol. 21, 354–361 (2011).
  CAS PubMed Google Scholar
• Modarresi, F. et al. Inhibition of natural antisense transcripts in vivo results in gene-specific transcriptional upregulation. Nature Biotech. 30, 453–459 (2012). This is the first in vivo demonstration of the efficacy of antagoNATs.
  CAS Google Scholar
• Li, L. C. et al. Small dsRNAs induce transcriptional activation in human cells. Proc. Natl Acad. Sci. USA 103, 17337–17342 (2006).
  CAS PubMed PubMed Central Google Scholar
• Janowski, B. A. et al. Activating gene expression in mammalian cells with promoter-targeted duplex RNAs. Nature Chem. Biol. 3, 166–173 (2007).
  CAS Google Scholar
• Scheele, C. et al. The human PINK1 locus is regulated in vivo by a non-coding natural antisense RNA during modulation of mitochondrial function. BMC Genomics 8, 74 (2007).
  PubMed PubMed Central Google Scholar
• Hopkins, A. L. & Groom, C. R. The druggable genome. Nature Rev. Drug Discov. 1, 727–730 (2002).
  CAS Google Scholar
• Desnick, R. J. & Schuchman, E. H. Enzyme replacement therapy for lysosomal diseases: lessons from 20 years of experience and remaining challenges. Annu. Rev. Genom. Hum. Genet. 13, 307–335 (2012).
  CAS Google Scholar
• Dirin, M. & Winkler, J. Influence of diverse chemical modifications on the ADME characteristics and toxicology of antisense oligonucleotides. Expert Opin. Biol. Ther. 2 Mar 2013 (10.1517/14712598.2013.774366).
• Jones, B. K., Levorse, J. M. & Tilghman, S. M. Igf2 imprinting does not require its own DNA methylation or H19 RNA. Genes Dev. 12, 2200–2207 (1998).
  CAS PubMed PubMed Central Google Scholar
• Schorderet, P. & Duboule, D. Structural and functional differences in the long non-coding RNA Hotair in mouse and human. PLoS Genet. 7, e1002071 (2011).
  CAS PubMed PubMed Central Google Scholar
• Nakagawa, S., Naganuma, T., Shioi, G. & Hirose, T. Paraspeckles are subpopulation-specific nuclear bodies that are not essential in mice. J. Cell Biol. 193, 31–39 (2011).
  CAS PubMed PubMed Central Google Scholar
• Zhang, B. et al. The lncRNA Malat1 is dispensable for mouse development but its transcription plays a _cis_-regulatory role in the adult. Cell Rep. 2, 111–123 (2012).
  CAS PubMed PubMed Central Google Scholar
• Bennett, C. F. & Swayze, E. E. RNA targeting therapeutics: molecular mechanisms of antisense oligonucleotides as a therapeutic platform. Annu. Rev. Pharmacol. Toxicol. 50, 259–293 (2010).
  CAS PubMed Google Scholar
• Senn, J. J., Burel, S. & Henry, S. P. Non-CpG-containing antisense 2′-methoxyethyl oligonucleotides activate a proinflammatory response independent of Toll-like receptor 9 or myeloid differentiation factor 88. J. Pharmacol. Exp. Ther. 314, 972–979 (2005).
  CAS PubMed Google Scholar
• Krieg, A. M. Therapeutic potential of Toll-like receptor 9 activation. Nature Rev. Drug Discov. 5, 471–484 (2006).
  CAS Google Scholar
• Freier, S. & Watt, A. T. in Antisense Drug Technology: Principles, Strategies, and Applications (ed. Crooke, S. T.) 118–138 (CRC Press, 2007).
  Google Scholar
• Xu, Z., Almudevar, A. & Mathews, D. H. Statistical evaluation of improvement in RNA secondary structure prediction. Nucleic Acids Res. 40, e26 (2012).
  CAS PubMed Google Scholar
• Lima, W. F. et al. Human RNase H1 discriminates between subtle variations in the structure of the heteroduplex substrate. Mol. Pharmacol. 71, 83–91 (2007).
  CAS PubMed Google Scholar
• Carroll, J. B. et al. Potent and selective antisense oligonucleotides targeting single-nucleotide polymorphisms in the Huntington disease gene / allele-specific silencing of mutant huntingtin. Mol. Ther. 19, 2178–2185 (2011).
  CAS PubMed PubMed Central Google Scholar
• Stein, C. A. The experimental use of antisense oligonucleotides: a guide for the perplexed. J. Clin. Invest. 108, 641–644 (2001).
  CAS PubMed PubMed Central Google Scholar
• Shim, M. S. & Kwon, Y. J. Efficient and targeted delivery of siRNA in vivo. FEBS J. 277, 4814–4827 (2010).
  CAS PubMed Google Scholar
• Huang, L. & Liu, Y. In vivo delivery of RNAi with lipid-based nanoparticles. Annu. Rev. Biomed. Eng. 13, 507–530 (2011).
  CAS PubMed Google Scholar
• Pollack, A. F.D.A. approves genetic drug to treat rare disease. New York Times [online], (2013).
• Juliano, R. L., Carver, K., Cao, C. & Ming, X. Receptors, endocytosis, and trafficking: the biological basis of targeted delivery of antisense and siRNA oligonucleotides. J. Drug Target 21, 27–43 (2013).
  CAS PubMed Google Scholar
• Wahlestedt, C. et al. Antisense oligodeoxynucleotides to NMDA-R1 receptor channel protect cortical neurons from excitotoxicity and reduce focal ischaemic infarctions. Nature 363, 260–263 (1993).
  CAS PubMed Google Scholar
• Wahlestedt, C., Pich, E. M., Koob, G. F., Yee, F. & Heilig, M. Modulation of anxiety and neuropeptide Y-Y1 receptors by antisense oligodeoxynucleotides. Science 259, 528–531 (1993).
  CAS PubMed Google Scholar
• Standifer, K. M., Chien, C. C., Wahlestedt, C., Brown, G. P. & Pasternak, G. W. Selective loss of δ opioid analgesia and binding by antisense oligodeoxynucleotides to a δ opioid receptor. Neuron 12, 805–810 (1994).
  CAS PubMed Google Scholar
• Yee, F., Ericson, H., Reis, D. J. & Wahlestedt, C. Cellular uptake of intracerebroventricularly administered biotin- or digoxigenin-labeled antisense oligodeoxynucleotides in the rat. Cell. Mol. Neurobiol. 14, 475–486 (1994).
  CAS PubMed Google Scholar
• Southwell, A. L., Skotte, N. H., Bennett, C. F. & Hayden, M. R. Antisense oligonucleotide therapeutics for inherited neurodegenerative diseases. Trends Mol. Med. 18, 634–643 (2012).
  CAS PubMed Google Scholar
• Hayek, S. M., Deer, T. R., Pope, J. E., Panchal, S. J. & Patel, V. B. Intrathecal therapy for cancer and non-cancer pain. Pain Physician 14, 219–248 (2011).
  PubMed Google Scholar
• Rigo, F., Hua, Y., Krainer, A. R. & Bennett, C. F. Antisense-based therapy for the treatment of spinal muscular atrophy. J. Cell Biol. 199, 21–25 (2012).
  CAS PubMed PubMed Central Google Scholar
• Gommans, W. M., Haisma, H. J. & Rots, M. G. Engineering zinc finger protein transcription factors: the therapeutic relevance of switching endogenous gene expression on or off at command. J. Mol. Biol. 354, 507–519 (2005).
  CAS PubMed Google Scholar
• Klug, A. Zinc finger peptides for the regulation of gene expression. J. Mol. Biol. 293, 215–218 (1999).
  CAS PubMed Google Scholar
• Matera, A. G., Terns, R. M. & Terns, M. P. Non-coding RNAs: lessons from the small nuclear and small nucleolar RNAs. Nature Rev. Mol. Cell Biol. 8, 209–220 (2007).
  CAS Google Scholar
• Bachellerie, J. P., Cavaille, J. & Huttenhofer, A. The expanding snoRNA world. Biochimie 84, 775–790 (2002).
  CAS PubMed Google Scholar
• Bartel, D. P. MicroRNAs: target recognition and regulatory functions. Cell 136, 215–233 (2009).
  CAS PubMed PubMed Central Google Scholar
• Fabian, M. R. & Sonenberg, N. The mechanics of miRNA-mediated gene silencing: a look under the hood of miRISC. Nature Struct. Mol. Biol. 19, 586–593 (2012).
  CAS Google Scholar
• Rother, S. & Meister, G. Small RNAs derived from longer non-coding RNAs. Biochimie 93, 1905–1915 (2011).
  PubMed Google Scholar
• Pruijn, G. J., Wingens, P. A., Peters, S. L., Thijssen, J. P. & van Venrooij, W. J. Ro RNP associated Y RNAs are highly conserved among mammals. Biochim. Biophys. Acta 1216, 395–401 (1993).
  CAS PubMed Google Scholar
• Jeon, Y. & Lee, J. T. YY1 tethers Xist RNA to the inactive X nucleation center. Cell 146, 119–133 (2011).
  CAS PubMed PubMed Central Google Scholar
• Schmitz, K. M., Mayer, C., Postepska, A. & Grummt, I. Interaction of noncoding RNA with the rDNA promoter mediates recruitment of DNMT3b and silencing of rRNA genes. Genes Dev. 24, 2264–2269 (2010).
  CAS PubMed PubMed Central Google Scholar
• Martianov, I., Ramadass, A., Serra Barros, A., Chow, N. & Akoulitchev, A. Repression of the human dihydrofolate reductase gene by a non-coding interfering transcript. Nature 445, 666–670 (2007).
  CAS PubMed Google Scholar
• Beerli, R. R. & Barbas, C. F. Engineering polydactyl zinc-finger transcription factors. Nature Biotech. 20, 135–141 (2002).
  CAS Google Scholar
• Cayre, A., Rossignol, F., Clottes, E. & Penault-Llorca, F. aHIF but not HIF-1α transcript is a poor prognostic marker in human breast cancer. Breast Cancer Res. 5, R223–230 (2003).
  CAS PubMed PubMed Central Google Scholar
• Thrash-Bingham, C. A. & Tartof, K. D. aHIF: a natural antisense transcript overexpressed in human renal cancer and during hypoxia. J. Natl Cancer Inst. 91, 143–151 (1999).
  CAS PubMed Google Scholar
• Zolk, O., Solbach, T. F., Eschenhagen, T., Weidemann, A. & Fromm, M. F. Activation of negative regulators of the hypoxia-inducible factor (HIF) pathway in human end-stage heart failure. Biochem. Biophys. Res. Commun. 376, 315–320 (2008).
  CAS PubMed Google Scholar
• Pasmant, E. et al. Characterization of a germ-line deletion, including the entire INK4/ARF locus, in a melanoma-neural system tumor family: identification of ANRIL, an antisense noncoding RNA whose expression coclusters with ARF. Cancer Res. 67, 3963–3969 (2007).
  CAS PubMed Google Scholar
• Pasmant, E. et al. Role of noncoding RNA ANRIL in genesis of plexiform neurofibromas in neurofibromatosis type 1. J. Natl Cancer Inst. 103, 1713–1722 (2011).
  CAS PubMed Google Scholar
• Pasmant, E., Sabbagh, A., Vidaud, M. & Bieche, I. ANRIL, a long, noncoding RNA, is an unexpected major hotspot in GWAS. FASEB J. 25, 444–448 (2011).
  CAS PubMed Google Scholar
• Annilo, T., Kepp, K. & Laan, M. Natural antisense transcript of natriuretic peptide precursor A (NPPA): structural organization and modulation of NPPA expression. BMC Mol. Biol. 10, 81 (2009).
  PubMed PubMed Central Google Scholar
• Parenti, R., Paratore, S., Torrisi, A. & Cavallaro, S. A natural antisense transcript against Rad18, specifically expressed in neurons and upregulated during β-amyloid-induced apoptosis. Eur. J. Neurosci. 26, 2444–2457 (2007).
  PubMed Google Scholar
• Zhang, H., Gao, S. & De Geyter, C. A natural antisense transcript, BOKAS, regulates the pro-apoptotic activity of human Bok. Int. J. Oncol. 34, 1135–1138 (2009).
  CAS PubMed Google Scholar
• Chung, D. W., Rudnicki, D. D., Yu, L. & Margolis, R. L. A natural antisense transcript at the Huntington's disease repeat locus regulates HTT expression. Hum. Mol. Genet. 20, 3467–3477 (2011).
  CAS PubMed PubMed Central Google Scholar
• Yu, W. et al. Epigenetic silencing of tumour suppressor gene p15 by its antisense RNA. Nature 451, 202–206 (2008).
  CAS PubMed PubMed Central Google Scholar
• Ozgur, E. et al. Differential expression of long non-coding RNAs during genotoxic stress-induced apoptosis in HeLa and MCF-7 cells. Clin. Exp. Med. 10 Apr 2012 (10.1007/s10238-012-0181-x).
• Hu, W., Yuan, B., Flygare, J. & Lodish, H. F. Long noncoding RNA-mediated anti-apoptotic activity in murine erythroid terminal differentiation. Genes Dev. 25, 2573–2578 (2011).
  CAS PubMed PubMed Central Google Scholar
• Paralkar, V. R. & Weiss, M. J. A new 'Linc' between noncoding RNAs and blood development. Genes Dev. 25, 2555–2558 (2011).
  CAS PubMed PubMed Central Google Scholar
• Mourtada-Maarabouni, M., Pickard, M. R., Hedge, V. L., Farzaneh, F. & Williams, G. T. GAS5, a non-protein-coding RNA, controls apoptosis and is downregulated in breast cancer. Oncogene 28, 195–208 (2009).
  CAS PubMed Google Scholar